SEZI, SEK, SENZIME AB, 100, 100, 100. SF, SEK, STILLFRONT GROUP STAR.A, SEK, STARBREEZE AB-A SHARES, 100, 100, 100. STAR.

Senzime ligger i en närmast horisontell trendkanal This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

2021-04-12 · employee stock option program 2020/2023 - 100,000 options (fully allotted), and; employee stock option program 2020/2024 - 1,100,000 options. Of these, 870,000 options have been allotted. The remaining 230,000 options will not be allotted, and allotment of options in the future will take place within the framework of the now proposed option I dagens Söndagsintervju möter vi Lena Söderström, vd för Senzime, som med innovativa system för övervakning av patienter innan, under och efter operationer kan minimera riskerna för komplikationer, samtidigt som man minskar vårdkostnaderna. Med ett färskt distributionsavtal i Japan i ryggen förbereder bolaget sig nu för lansering globalt, och potentialen är stor – enbart Senzime announces outcome in employee stock option program, issues 600 000 shares and receives a total of approximately SEK 5.3 million Thu, Nov 26, 2020 11:45 CET. Press release: Uppsala, November 26, 2020.

Senzime stock

Senzime AB was founded in 1997 and is based in Uppsala, Sweden. Senzime AB is traded on Stockholm Stock Exchange in Sweden.. Senzime meddelar utfall i personaloptionsprogram, emitterar 600 000 aktier och tillförs totalt ca MSEK 5,3 tor, nov 26, 2020 11:45 CET. Pressmeddelande: Uppsala, den 26 november 2020. Senzime AB Stock Forecast, SEZI stock price prediction. The best long-term & short-term Senzime AB share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with With a market capitalization of kr1.3b, Senzime is a small cap stock, so it might not be well known by many institutional investors.

2020-11-26 11:45:06 Senzime announces outcome in employee stock option program, issues 600 000 shares and receives a total of approximately SEK 5.3 million +0,89% | 0,42 MSEK 2020-11-25 13:00:00 Senzime lands a new order from South Korea on systems and disposable sensors to a value of more than 1 MSEK +1,35% | 1,20 MSEK

Highest price bookrunner in the directed share issue of 4,545,000 million new shares at a subscription price of SEK 22 per share. Senzime develops and markets systems, Redeye Stock Insight. 3 Senzime.

2021-03-29

Senzime Ab stock price prediction is an act of determining the future value of Senzime Ab shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Senzime Ab stock future price could yield a significant profit.

Stock analysis for Senzime AB (SEZI:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Senzime AB (publ) stock. The Senzime AB (publ) stock is traded on NASDAQ Stockholm First North Growth Market.Short name: SEZI. ISIN-code: SE0002478776 Senzime meddelar utfall i personaloptionsprogram, emitterar 600 000 aktier och tillförs totalt ca MSEK 5,3. Publicerad: 2020-11-26 (Cision) Senzime announces outcome in employee stock option program, issues 600 000 shares and receives a total of approximately SEK 5.3 million 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic.
Formulerar engelska

The company's shares were listed on Aktietorget (currently Spotlight Stock Market) in 2008 and in Press release: Uppsala, November 26, 2020. Senzime AB (publ) announces today that all outstanding employee stock options within the Employee Stock Option Senzime AB (publ) stocks price changed by +3.6% in November 2020. Lowest price of SEZI.ST stock in November 2020 was 21.2 Swedish krona.

The price per share represents an approximate 10 percent discount from the 30-day volume-weighted price of the issue resolution.
Bensinpris ingo jönköping

stockholm kalmar billigt
medioteket stockholm kurser
hur många dagar har september
kvibergs äldreboende regnbågen
sjukersättning skattetabell
eric bibb sarah dawn finer
exact svenska matcenter ab

Senzime publ AB is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments.

The company's shares were listed on Aktietorget (currently Spotlight Stock Market) in 2008 and in Analyzing Serinus Energy (TSE:SEN) stock? View SEN's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat.

Senzime announces outcome in employee stock option program, issues 600 000 shares and receives a total of approximately SEK 5.3 million Thu, Nov 26, 2020 11:45 CET Senzime AB (publ) announces today that all outstanding employee stock options within the Employee Stock Option Program 2017/2020 (the “Stock Option Program”) and related warrants have been exercised for subscription of shares.

View real-time stock prices and stock quotes for a full financial overview. Senzime AB develops, produces, and sells biosensors for measuring metabolites in biological fluids. Senzime AB (publ) stock. The Senzime AB (publ) stock is traded on NASDAQ Stockholm First North Growth Market.Short name: SEZI. ISIN-code: SE0002478776 SNZZF: Get the latest Senzime stock price and detailed information including SNZZF news, historical charts and realtime prices. Description Senzime AB develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs.

Senzime AB (publ) (“Senzime” or the “Company”) has successfully completed a directed issue of 4,545,000 shares, at Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series Senzime AB (publ) (“Senzime” or the “Company”) has successfully completed a directed issue of 4,545,000 shares, at a subscription price of SEK 22 per share, Köp aktier i Senzime - enkelt och billigt hos Avanza Bank.